Recruiting RSV Studies in Aurora
About RSV Clinical Trials in Aurora
Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms but can be serious in infants, older adults, and immunocompromised individuals. New preventive therapies including monoclonal antibodies and vaccines have recently been approved. Clinical trials continue to investigate improved treatments.
There are currently 2 rsv clinical trials recruiting participants in Aurora, IL. These studies are seeking a combined 687 participants. Research is being sponsored by Pfizer, Blue Lake Biotechnology Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
RSV Clinical Trials in Aurora — FAQ
Are there rsv clinical trials in Aurora?
Yes, there are 2 rsv clinical trials currently recruiting in Aurora, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Aurora?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.
Are clinical trials in Aurora free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.
What rsv treatments are being tested?
The 2 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for rsv.
Data updated July 13, 2026 from ClinicalTrials.gov